Editas Therapeutics is developing a gene-editing therapy called reni-cel for Sickle Cell Disease and beta-thalassemia.The competitive landscape for gene-editing therapies for SCD is strengthening with...
Source LinkEditas Therapeutics is developing a gene-editing therapy called reni-cel for Sickle Cell Disease and beta-thalassemia.The competitive landscape for gene-editing therapies for SCD is strengthening with...
Source Link
Comments